Agenda

Hacking Medicine Madrid is part of Ideas into Action, a series of integrated events designed to help Madrid’s healthcare technology innovators turn their ideas into projects with real potential for impact. The Ideas into Action series includes the IDEA2 Madrid Showcase, Hacking Medicine, and the Project Futures Forum. 

Hosted by

American space logo stripe


The mentors

Mentors are experts in their fields who are experienced with entrepreneurial technology innovation. They circulate through the hackathon offering advice and support to teams as they develop their ideas.


The MCs

The Hacking Medicine Madrid MCs are highly seasoned members of MIT Hacking Medicine who have supported hackathons around the world.

MC Tatyana Gubin

Tatyana Gubin

Tatyana is an MIT student studying mechanical engineering and pursuing medical device design. Her diverse work at Massachusetts General Hospital (MGH) and MIT includes the development of a faster tissue ischemia diagnostic device and low-cost, 3D-printed myoelectric prosthetic arms, the latter of which have been showcased in the MIT museum. Through her work with MIT Hacking Medicine and her research at MGH, she seeks to merge the medical world with mechanical innovation.

MC Christopher Lee

Christopher Lee

Christopher Lee is a PhD student at Harvard Medical School and the Massachusetts Institute of Technology, within the joint Harvard-MIT Health Sciences and Technology program. Chris currently works underneath Professor Michael J. Cima focusing on translational medical devices.

He graduated in 2012 from the University of Connecticut with a bachelor’s degree in Biomedical Engineering and concentration in Electrical Engineering. Chris continued on to obtain a master’s degree in Bioengineering Innovation and Design from Johns Hopkins University, a degree catered towards the commercialization of medical devices and biotechnology.

Chris also has management consulting experience working as an analyst for the Innovation and Technology Management group within Sagentia, where he provided front-end product development and strategy consulting services for medical, industrial, and consumer clients. He also has some experience working in venture capital with RA Capital Management, a Boston based crossover fund investing in the biotechnology space.

Chris has been nationally recognized for his pursuits in numerous business plan competitions and academic achievements. He has been an author on over a half-dozen publications, and currently holds one patent.

 



IDEA2 Madrid

Connect with international experts, focus your project ideas, & accelerate your project’s healthcare impact

IDEA² Madrid helps the region’s emerging biomedical technology innovators and entrepreneurs refine their project ideas and connect with the expertise to help realize them.

2015 CALL FOR PRE-PROPOSALS IS OPEN

Learn more about IDEA2 Madrid and apply




Project Futures Forum

Advice and ideas to take your project to the next level 

Discover paths for taking projects to the next stage in this interactive session, led by a panel of experienced professionals. Final Hacking Medicine pitches and the Project Futures Forum begin Saturday, February 28, at 15:30

bryant

Peter Bryant
Moderator

Professor of Entrepreneurship, IE Business School

Peter Bryant is an Assistant Professor of Entrepreneurship at IE Business School in Madrid. He began his academic career after earning his PhD in Management in 2006 from Macquarie University in Sydney, Australia. During the preceding fifteen years, Peter worked as a manager in the airline, banking, consulting and venture capital industries. He subsequently managed the commercialization of new technologies through the creation of spinoff companies at The University of Sydney. In this role, he accomplished successful IPOs and VC deals. In his current academic career, Peter researches in the fields of entrepreneurial management and strategy, and their relationship to the dynamics of industrial change and the evolution of capabilities.

Luis del Cañizo

Co-founder, iDoctus

Luis del Cañizo is an entrepreneur and co-founder of mHealth company iDoctus based in Madrid and expanding throughout Iberoamérica. He began his entrepreneurial journey as alumni of Sloan MIT, as co-founder of Despegar.com. Since then, Luis has worked in several technology-based startups – some successful, some failures- across different industries trying to align technology with capital, talent, and market readiness. In less than two years iDoctus has become the leading point-of-care solution seek by physicians to make safer & faster clinical decisions using smartphones and tablets. Luis is always looking for talented people to join him. He holds three degrees from MIT, as a Fulbright and Fundación Rafael del Pino scholar. 

Marisol Quintero

CEO, Bioncotech Therapeutics

Marisol Quintero holds a PhD degree in Pharmacology from the University of Valencia-University College London (2006) and an Executive MBA from the IE Business School in Madrid (2009). In 2008, she joined the Marcelino Botín Foundation as Technology Transfer Manager in charge of an innovative initiative aimed at supporting the development of products and services resulting from technology transfer processes from biomedical research laboratories to business. She has excelled identifying business opportunities in novel technologies. Her passion and commitment to Technology Transfer has been key when selling the business ideas to potential investors and development partners – developed understanding of interests and requirements of companies on the pharmaceutical and biotechnology industries. She has acquired experience in negotiating with prospective partners to secure the development and translation of a technology, and managing the IP protection process. In 2011 she joined CNIO as Director of Innovation, responsible for coordinating and managing the two applied research programs, The Biotechnology and Experimental Therapeutics, and it served as a mechanism to translate promising new discoveries from the laboratory to the commercial development stage and to society in general. Since October 2013, Marisol is the CEO of Bioncotech Therapeutics, a biopharmaceutical company dedicated to the development of new oncologic treatments.

Ángel Santos

Director of Business Development, CRB Inverbío

Ángel Santos has extensive experience n the international business world, acquired over 25 years in Spain, the UK and USA working in Johnson’s Wax and Lilly. In his final period at Johnson he was Vice President of Marketing and Operations for the professional business in North America, where he was responsible for the development of strategy and solutions for the health and food service markets. He was previously responsible for the development of new technological solutions and for various innovation projects of global impact. He has demonstrated experience in acquisitions, mergers, and exit strategies. Before becoming part of Johnson, he worked for Lilly in several positions and divisions of the pharmaceutical group. He has been a Director for the Center for Hospitality Research of the Hotel Management School at Cornell University. He is an Agronomist (Universidad Politécnica de Madrid) and has been involved in numerous specialized postgraduate courses.


Hosted by

American Space Madrid

at the International Institute
Calle de Miguel Ángel, 8, 28010
Madrid

American space logo stripe